244
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Methyl-Gag, Ifosfamide, Methotrexate and Etoposide (Mime) as Salvage Therapy for Hodgkin's Disease and Non-Hodgkin's Lymphoma

, , &
Pages 297-301 | Accepted 15 May 1989, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dìlek Dìnçol, Fìkrì ìçli, Handan Karaoìuz, Fìlìz Clay, Alì Arican, Ahmet Demìrkazlk & Hakan Akbulut. (1995) Mesna/Ifosfamide, Mitoxantrone, Etoposide, Bleomycin, Vincristine, Prednisone (Mine-Bop) Combination Chemotherapy In The Treatment Of Refractory And Relapsed Non-Hodgkin'S Lymphoma. Acta Oncologica 34:7, pages 937-940.
Read now

Articles from other publishers (7)

I. Radman, N. Bašić, B. Labar, J. Kovačević, I. Aurer, V. Bogdanić, S. Zupančić-Šalek, D. Nemet, J. Jakić-Razumović, M. Mrsić, F. Šantek, L. Grgić-Markulin & D. Boban. (2002) Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin’s disease (Croatian experience). Annals of Oncology 13:10, pages 1650-1655.
Crossref
Rose‐Marie Amini, Bengt Glimelius, Anita Gustavsson, Tor Ekman, Martin Erlanson, Eva Haapaniemi & Gunilla Enblad. (2002) A population‐based study of the outcome for patients with first relapse of Hodgkin's lymphoma. European Journal of Haematology 68:4, pages 225-232.
Crossref
Gunilla Enblad, Hans Hagberg, Anita Gustavsson & Bengt Glimelius. (2009) Methyl‐GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study. European Journal of Haematology 60:3, pages 166-171.
Crossref
Joel E. Wright. 1997. Cancer Therapeutics. Cancer Therapeutics 23 79 .
H. Hagberg & E. Kimby. (1996) Treatment of aggressive non-Hodgkin’s lymphoma in adults — Are we doing any better?. Medical Oncology 13:4, pages 185-194.
Crossref
Lena Specht. (1996) Prognostic factors in Hodgkin's disease. Seminars in Radiation Oncology 6:3, pages 146-161.
Crossref
G. Hopfinger, R. Heinz, E. Koller, B. Schneider & E. Pittermann. (2009) Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non‐Hodgkin's lymphoma. European Journal of Haematology 55:4, pages 223-227.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.